Weighing the significant considerations at stake when a plaintiff asserts tort claims based on a harmful flaw in the design or labeling of the brand-name and generic versions of a drug,290 the liability framework described here seeks to achieve a fair balance of the interests of injured plaintiffs, brand-name manufacturers, and their generic counterparts.